Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Lupin gets USFDA nod to market cancer drug

      Lupin gets USFDA nod to market cancer drug

      supriya kashyap kashyap1 March 2017 10:48 AM IST
      New Delhi : Pharma major Lupin Ltd has received final approval from the USFDA to market sodium sulfate, potassium sulfate, magnesium sulfate oral...
      FDA approves Xermelo for carcinoid syndrome diarrhea

      FDA approves Xermelo for carcinoid syndrome diarrhea

      supriya kashyap kashyap1 March 2017 10:48 AM IST
      The U.S. Food and Drug Administration approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the...
      Zydus subsidiary receives USFDA nod to market Tamiflu drug

      Zydus subsidiary receives USFDA nod to market Tamiflu drug

      supriya kashyap kashyap28 Feb 2017 12:05 PM IST
      New Delhi : Drug firm Zydus Cadila’s US subsidiary has received approval from the US health regulator to market oseltamivir phosphate capsules used...
      Jubilant gets USFDA nod for generic anti-fungal capsules

      Jubilant gets USFDA nod for generic anti-fungal capsules

      supriya kashyap kashyap28 Feb 2017 12:05 PM IST
      New Delhi : Jubilant Life Sciences said it has received approval from the US health regulator to market generic Sporanox capsules, used to treat...
      Lupin arm in pact to distribute anti-depressant drug in Japan

      Lupin arm in pact to distribute anti-depressant drug in Japan

      supriya kashyap kashyap28 Feb 2017 12:04 PM IST
      New Delhi : Drug major Lupin Ltd said its Japanese subsidiary Kyowa Pharmaceutical Industry Co Ltd has entered into an agreement with Astellas Pharma...
      US FDA issues draft norms for difluprednate, an ophthalmic emulsion to treat eye swelling and pain

      US FDA issues draft norms for difluprednate, an ophthalmic emulsion to treat eye swelling and pain

      supriya kashyap kashyap28 Feb 2017 9:10 AM IST
      Bengaluru : The USFDA has issued a draft guidance for the active ingredient difluprednate which is an ophthalmic emulsion with a strength of 0.05 per...
      India enters age of 3D printed body parts

      India enters age of 3D printed body parts

      supriya kashyap kashyap27 Feb 2017 1:00 PM IST
      Gurgaon : 3D printed body parts have become a reality in India, a game changer which promises to alter the medical landscape in India.The courage of a...
      FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis

      FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis

      supriya kashyap kashyap27 Feb 2017 11:06 AM IST
      The U.S. Food and Drug Administration cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic...
      Govt must scale up production of active ingredients of drugs

      Govt must scale up production of active ingredients of drugs

      supriya kashyap kashyap27 Feb 2017 11:05 AM IST
      New Delhi : The Centre should scale up the production of active ingredients used in drugs to meet the country's need, a government institute has said...
      Indias pharma barons are reporting delays in digitizing labs

      India's pharma barons are reporting delays in digitizing labs

      supriya kashyap kashyap27 Feb 2017 11:03 AM IST
      Ari Altstedter : Heads of two of India’s largest drug makers said integration of electronic systems to prevent quality lapses in factories is going...
      Pfizer subpoenaed in US over patient assistance plans

      Pfizer subpoenaed in US over patient assistance plans

      supriya kashyap kashyap27 Feb 2017 11:03 AM IST
      Pfizer Inc said it received subpoenas from the U.S. Attorney's Office for the District of Massachusetts related to its support for organizations that...
      Sun Pharma arm SPARC gets I-T demand notice for Rs 32.87 crore

      Sun Pharma arm SPARC gets I-T demand notice for Rs 32.87 crore

      supriya kashyap kashyap26 Feb 2017 10:43 AM IST
      New Delhi : Sun Pharma Advanced Research Company (SPARC) said it has received a demand notice from income tax authorities for a sum of Rs 32.87...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok